跳至主要内容
临床试验/NCT04947605
NCT04947605进行中(未招募)不适用

Epidemiological Landscape of Cervical Cancer in Latin America .

Latin American Cooperative Oncology Group13 个研究点 分布在 4 个国家目标入组 524 人开始时间: 2021年11月4日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
524
试验地点
13
主要终点
- Summarize the histologic subtype

研究概览

简要总结

A portrait of clinical and epidemiological aspects of cervical cancer in Latin America is required to understand the high frequency of cervical cancer despite the existence of effective preventive tools. A better understanding of the current situation of this scenario will provide a valuable groundwork for the development of national and cooperative programs to improve cervical cancer prevention and treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women > 18 years.
  • Histologically proven cervical carcinoma
  • Diagnosis of carcinoma of the cervix since January 2018 or newly diagnosis or recurrent disease during the period of study recruitment.
  • Any histology of cervical cancer at time of diagnosis.
  • FIGO stage IB2-IVA
  • Have available and adequate medical records for data collection
  • Accept to participate in the project and sign the informed consent (if applicable)

排除标准

  • FIGO stage I and IB1
  • Non-invasive cervical cancer
  • Synchronous tumor or second primary tumor in the last five years (exception for thyroid cancer or skin cancer non melanoma)

结局指标

主要结局

- Summarize the histologic subtype

时间窗: January of 2028

Summarize the histologic subtype, assessed by the anatomopathological assay of the tumor sample and the stage at diagnosis, assessed by FIGO stage (International Federation of Gynecology and Obstetrics (FIGO) staging of cancer of the cervix uteri - 2018), using gynecological exam. Image studies and TNM stage (AJCC 8th edition) will also be used to assess stage at diagnosis when available.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验